Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
ohm20's Profile
Displaying 801-850 of 6028 result(s).
CYDY CytoDyn Inc
04/15/2024 5:58:21 PM
Let the name Cytodyn turn to dust. (19)
CYDY CytoDyn Inc
04/15/2024 5:54:02 PM
The judge's ruling that the emails (18)
CYDY CytoDyn Inc
04/15/2024 5:10:38 PM
Vertex pays $4.9 Billion for Alpine (13)
CYDY CytoDyn Inc
04/15/2024 4:39:42 PM
I wonder if insulin resistance may (10)
CYDY CytoDyn Inc
04/12/2024 2:32:28 PM
Why this was not pursued ??? Lack o (4)
CYDY CytoDyn Inc
04/12/2024 8:03:21 AM
Jeff Murray, MD, MPH Hippocratic Oa (8)
CYDY CytoDyn Inc
04/12/2024 6:40:42 AM
Re: NP's Docket: On Exhibit 1 pages (2)
CYDY CytoDyn Inc
04/12/2024 12:00:52 AM
Speaking of Deciphering...someone c (13)
CYDY CytoDyn Inc
04/11/2024 4:42:51 PM
Any chance the "I hate them" commen (10)
CYDY CytoDyn Inc
04/10/2024 11:51:57 PM
You may know him as bank robber Ios (3)
CYDY CytoDyn Inc
04/08/2024 9:07:00 PM
Good find. 1. Long COVID leads to o (20)
CYDY CytoDyn Inc
04/03/2024 10:09:32 PM
The contract has been passed around (4)
CYDY CytoDyn Inc
04/03/2024 8:59:18 PM
I decided to hunt down the Cytodyn/ (13)
CYDY CytoDyn Inc
04/03/2024 7:13:10 PM
I would expect an immediate motion (7)
CYDY CytoDyn Inc
04/03/2024 5:12:01 PM
I thought the original Vyera deal w (7)
CYDY CytoDyn Inc
04/03/2024 3:39:04 PM
This is all greek to me. Can you ma (5)
CYDY CytoDyn Inc
04/03/2024 2:22:39 AM
Those are just patents that cover t (5)
CYDY CytoDyn Inc
04/03/2024 2:16:33 AM
It had me a bit baffled as to why E (10)
CYDY CytoDyn Inc
04/03/2024 12:59:33 AM
The actual company name is Phoenixu (5)
CYDY CytoDyn Inc
04/03/2024 12:29:41 AM
Hey ohm, speaking of a phase 3 for (7)
CYDY CytoDyn Inc
04/03/2024 12:23:43 AM
Cidara has another drug CCR5-001 wh (5)
CYDY CytoDyn Inc
04/02/2024 2:27:36 PM
Why then do many elderly have a del (15)
CYDY CytoDyn Inc
04/02/2024 1:24:09 AM
If Phoenix AG is dropped they'll ha (5)
CYDY CytoDyn Inc
04/02/2024 1:19:24 AM
Hopefully we get a very complete se (8)
CYDY CytoDyn Inc
04/02/2024 1:17:12 AM
I was excited the first few years r (20)
CYDY CytoDyn Inc
04/01/2024 10:37:46 PM
Compared with participants receivin (6)
CYDY CytoDyn Inc
04/01/2024 10:36:13 PM
Could they have low CCR5 levels as (12)
CYDY CytoDyn Inc
04/01/2024 8:21:08 PM
Australian of the Year Richard Scol (17)
CYDY CytoDyn Inc
04/01/2024 8:07:29 PM
Hm, that's true....also rantes didn (4)
CYDY CytoDyn Inc
04/01/2024 7:55:22 PM
So, when a certain patent does come (7)
CYDY CytoDyn Inc
04/01/2024 7:26:37 PM
Feb. 2023 Cytodyn patent: Dosen't t (6)
CYDY CytoDyn Inc
04/01/2024 7:18:09 PM
CDTX - a competitor to CYDY's CCR5 (11)
CYDY CytoDyn Inc
04/01/2024 7:02:32 PM
Question for the board: What are yo (7)
CYDY CytoDyn Inc
04/01/2024 6:51:18 PM
If LL is approved in oncology becau (8)
CYDY CytoDyn Inc
04/01/2024 6:40:49 PM
For those who want to daydream abou (11)
CYDY CytoDyn Inc
04/01/2024 6:20:52 PM
From @Bio4 on Stocktwits. PASC disc (10)
CYDY CytoDyn Inc
04/01/2024 5:06:17 PM
This Inflammation trial cydy is doi (13)
CYDY CytoDyn Inc
04/01/2024 4:49:13 PM
Yet, only Dr. Pourhassan has been c (7)
CYDY CytoDyn Inc
03/15/2024 2:23:38 AM
Madrigal's drug for MASH/NASH appro (20)
CYDY CytoDyn Inc
03/14/2024 4:22:28 PM
Leronlimab was found to RAISE CCR5 (11)
CYDY CytoDyn Inc
03/13/2024 10:54:25 AM
NIH just announced 3 studies to inv (28)
CYDY CytoDyn Inc
03/11/2024 12:45:37 PM
The FDA will assign that to a cohor (7)
CYDY CytoDyn Inc
03/11/2024 12:37:53 PM
I took a look at the study and the (13)
CYDY CytoDyn Inc
03/11/2024 8:28:35 AM
For those of you in the know, is Le (10)
CYDY CytoDyn Inc
03/11/2024 8:23:05 AM
CYDY has still not presented viable (23)
CYDY CytoDyn Inc
03/11/2024 8:16:57 AM
Right to Try Investigational Drugs (11)
CYDY CytoDyn Inc
03/08/2024 8:19:23 AM
Assuming an infection/pathology,isn (5)
CYDY CytoDyn Inc
03/08/2024 7:46:34 AM
In an exploratory trial treating †(10)
CYDY CytoDyn Inc
03/06/2024 10:03:54 PM
They were looking at cytokines not (9)
CYDY CytoDyn Inc
03/06/2024 5:39:22 PM
And I'm not sure why the FDA wouldn (9)
Go to page:
  • << First
  • < Previous
  • 16
  • 17
  • Next >

Recent Articles

  • SHARC Energy Secures $1.57 Million in Convertible Debentures
  • Alpha Modus Enhances Financial Stability Through Strategic Exchange
  • Opus Genetics Advances Vision Restoration with FDA IND Clearance
  • Pelthos Therapeutics Success: Business Updates and Financial Results
  • Legend Biotech Welcomes New CFO Carlos Santos to Executive Team
  • DeFi Development Corp. Showcases Innovative Strategies in 2025
  • LIXTE Biotechnology: Major Updates and Future Directions
  • Investigation Launched: SelectQuote, Inc. Faces Class Action Suit
  • Nuvini Group Implements Innovative Executive Compensation Program
  • Flywire Corporation Faces Class Action Lawsuit: Shareholder Insights
  • Hepsiburada's Upcoming General Assembly Meeting Insights
  • Understanding the Capricor Therapeutics Lawsuit and Its Implications
  • STMicroelectronics Updates on Its Recent Share Buyback Endeavors
  • Petco Shareholder Class Action Lawsuit Announced by Bernstein
  • Schouw & Co. Updates on Share Buy-Back Program Progress
  • Schouw & Co. Launches Strategic Share Buy-Back Initiative
  • JDE Peet’s Boosts Share Buyback Amidst Growing Market Dynamics
  • JDE Peet's Recent Share Buyback Highlighted Strength
  • Key Resolutions from the Extraordinary General Meeting of KN Energies
  • Aditude's New CRO Anthony Gonsalves: Driving Revenue Growth
  • Sable Resources Reports Successful Completion of Geophysical Survey
  • OncoC4 Welcomes Shiniu Wei as New Chief Financial Officer
  • SUNation Energy Showcases Significant Growth in Q2 2025
  • Sweet's Tom Mizzone Discusses the Future of Sports Gaming
  • American Rare Earths Begins Test Mining at Cowboy State Mine
  • FTC Solar Engages Investors at Major Upcoming Conference Events
  • Exciting Developments in Chatterbox Technologies IPO Process
  • FTC Solar's Upcoming Investor Engagement and Innovations
  • Skyhawk Therapeutics Collaborates with Merck to Innovate Neurology Drugs
  • Soho House's Strategic Move to Private Ownership Explained
  • iRhythm's Zio LTCM Service Achieves Clinical Superiority in Study
  • RWA Wealth Partners Strengthens Market Position with New Deal
  • Insightful Insights from CNBC on Key Stocks to Watch
  • NRX Pharmaceuticals Reports Impressive Q2 Results and Updates
  • Braemar Hotels Successfully Completes New Loan Arrangement
  • NAVEE ST3 Pro: The Premier Electric Scooter of 2025
  • Alpha Modus Holdings Transforms Capital Structure for Growth
  • ETHZilla Launches New Brand to Enhance Ethereum Accumulation
  • Cuprina Holdings Updates Shareholders on Market Activity and Growth
  • DoControl Enhances SaaS Security with New AI-Driven Tools
  • Pelthos Therapeutics' Recent Achievements and Business Outlook
  • Valeo Networks Acquires SpliceNet: A New Chapter Begins
  • Scale Computing Achieves CRN 2025 Award for Excellence in IT
  • High Tide Projects Record Financial Performance in Q3 2025
  • SUNation Energy's Strong Q2 2025 Performance and Future Plans
  • U Power Partners with SAIC-Hongyan and UNEX EV for Trucking Innovation
  • Noteworthy Earnings Reports to Watch: Insights on Key Stocks
  • LaSalle Investment Management Secures Major Capital Commitments
  • Canopy USA Unveils New Executive Team to Boost Cannabis Growth
  • Nichiha Introduces Innovative ConcreteBoard for Modern Design
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site